SCHEMBL7209882

SCHEMBL7209882

Cc1ccc(-c2ccc(S(N)(=O)=O)cc2)n1C1CCCCC1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.78
CA2 P00918 12/20 0.56
CA9 Q16790 11/20 0.56
CA1 P00915 11/20 0.56
CA12 O43570 10/20 0.56
PTGS1 P23219 1/20 0.44
KDM4E B2RXH2 1/20 0.43
USP2 O75604 1/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43
HPGD P15428 1/20 0.43
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CA5A P35218 1/20 0.42
CA7 P43166 1/20 0.42
CA5B Q9Y2D0 1/20 0.42
KCNH2 Q12809 2/20 0.41
HRH3 Q9Y5N1 2/20 0.41
PDE4D Q08499 1/20 0.41
PDE7A Q13946 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7209869 0.87 PTGS2 (1.00) PTGS2CA2CA9CA1CA12
SCHEMBL8505098 0.76 PTGS2 (0.52) PTGS2CA2CA9CA1CA12
SCHEMBL7215974 0.73 PTGS2 (0.55) PTGS2CA2CA9CA1CA12
SCHEMBL21225325 0.71 MAPT (0.53) PTGS2KDM4ELMNAHPGD
SCHEMBL7210840 0.70 PTGS2 (0.76) PTGS2CA2CA9CA1CA12
SCHEMBL7216218 0.70 PTGS2 (0.76) PTGS2CA2CA9CA1CA12
SCHEMBL21225711 0.69 MAPT (0.55) PTGS2KDM4ELMNAHPGDNPSR1
SCHEMBL16054419 0.68 CHRNA7 (0.50) PTGS2CA2CA9CA1CA12
SCHEMBL7210689 0.68 PTGS2 (0.77) PTGS2CA2CA9CA1CA12
SCHEMBL5314020 0.68 CHRNA7 (0.60) PTGS2CA2CA9CA1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1369415-A1 Substituted pyrrolyl compounds for the treatment of inflammation G.D. SEARLE & CO. (US) 2003-12-10 EP claimed
EP-0946507-B1 SUBSTITUTED PYRROLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2003-09-24 EP claimed
EP-0946507-A1 SUBSTITUTED PYRROLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1999-10-06 EP claimed
WO-1998025896-A1 SUBSTITUTED PYRROLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-06-18 WO claimed
EP-1369415-A1 Substituted pyrrolyl compounds for the treatment of inflammation G.D. SEARLE & CO. (US) 2003-12-10 EP disclosed